Publications by authors named "Chijindu Nnaemeka Nwakama"
Article Synopsis
- Cardiovascular diseases are a major cause of death globally, often linked to dyslipidemia and various risk factors, including rare genetic conditions like familial chylomicronemia, which are frequently misdiagnosed.
- Traditional lipid-lowering treatments, primarily statins, have their drawbacks, leading to the exploration of new therapies like Olezarsen and Plozasiran that specifically target lipid metabolism pathways.
- Clinical trials show that these emerging therapies effectively improve cholesterol and triglyceride levels, presenting a promising option for managing dyslipidemia and reducing the risk of atherosclerotic cardiovascular diseases.